|
|
| *
- may be subscription-only |
|
|
- Achieve Life Sciences: Critical Milestone
Successfully Reached in ORCA-OL Cytisinicline
Clinical Trial Required for NDA Submission More
- BrainChild Bio: Will Clinically Advance BCB-276, an
Autologous B7-H3 Targeting CAR T-cell Therapy for
Incurable Pediatric Brain Tumors More
- Parse Biosciences: Quadruples Sample Multiplexing
Abilities for Evercode WT Mega Kits More
- Pluristyx: Immediate Availability of GMP-Compliant
PSXi013 iPSC Line for Advanced Therapy Development More
- Sana Biotechnology: Positive Clinical
Results From Type 1 Diabetes Study of Islet Cell
Transplantation Without Immunosuppression More
|
Spotlight:
|
|
Move
Faster In Our Flexible, Research-Ready
Vivarium Space
Schedule
A Tour
|
|
|
Section
Sponsor:
|
 |
|
|
|
|
- Adaptive Biotechnologies: Clinical Lab Fee
Schedule Rate of $2,007 for clonoSEQ Test for
Minimal Residual Disease Assessment is Effective as
of January 1st, 2025 More
- ICYMI: Immunome Reports Inducement Grants Under
Nasdaq Listing Rule 5635(c)(4) More
- Life Science Review of 2024: Analyzing
Developments and Planning for Future Success Video
- Navigating JPM Week 2025: Overcoming
Challenges and Maximizing Value Video
|
|
|
- Seven Biopharma Trends to Watch in 2025 More
- Subscribe to LifeSci Startup for Updates on
US Startups More
|
| SECTION SPONSOR: |
 |
|
|
- Big4Bio:Seattle Life Science Company
Directory More
|
NOTE:
EVENTS AND JOBS ARE FROM ALL BIG4BIO REGIONS
|
|
|
|
- (NEW) OPPORTUNITY: Senior
Director, Integrated Marketing & Communications-
REMOTE More
- (NEW) OPPORTUNITY: Clinical
Development Leader- New York, NY More
- OPPORTUNITY: Sales Executive- Hybrid More
- OPPORTUNITY: Senior Director of Business
Development- Remote More
- OPPORTUNITY: Vice President of North America Medical
Affairs- MA More
- OPPORTUNITY: Vice President of Sales &
Marketing, North America- Remote More
|
|
|
|
Section
Sponsor:
|
|
|
|
|
